Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
08/19/1998 | EP0858450A1 Quinolone compounds for the treatment of disorders caused by helicobacter pylori |
08/19/1998 | EP0858343A1 Continuous low-dose cytokine infusion therapy |
08/19/1998 | EP0858327A2 Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases |
08/19/1998 | EP0733057A4 Origin of replication complex genes, proteins and methods |
08/19/1998 | EP0688333B1 Steroid derivatives, pharmaceutical compositions containing them, and their use as antibiotics or disinfectants |
08/19/1998 | EP0660668B1 Iodine/resin disinfectant and a procedure for the preparation thereof |
08/19/1998 | EP0637247B1 Treatment of herpesvirus infection |
08/19/1998 | EP0460058B1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof for the manufacture of a medicament to treat endotoxin-associated disorders |
08/19/1998 | EP0422215B1 Antibacterial and antimalarial peptides |
08/19/1998 | EP0395706B1 Production of gonorrheal pi proteins and vaccines |
08/19/1998 | CN1190991A Human chemokine beta-11 and human chemokine alpha-1 |
08/19/1998 | CN1190972A Pyrmidine nucleoside derivatives |
08/19/1998 | CN1190963A 2-amino-benzoxanones for the treatment of viral infections |
08/19/1998 | CN1190958A N-oxides as antibacterial agents |
08/19/1998 | CN1190898A Vaccine composition containing polyribosylribitol phosphate and method for making same |
08/19/1998 | CN1190895A Use of ribavirin and interferon alpha for the treatment of hepatitis C |
08/19/1998 | CN1190892A Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field |
08/19/1998 | CN1190889A Zwitterionic forms of trovafloxacin |
08/19/1998 | CN1190650A Substituted phenyl acetanides, process for their preparation and intermediates thereof |
08/19/1998 | CA2223020A1 Human protein kinase hoacf72 |
08/18/1998 | US5795958 Library of glyco-peptides useful for identification of cell adhesion inhibitors |
08/18/1998 | US5795955 Amino acid sequences, t-cell epitopes of gag protein for htlv and amino acid sequences for b-cell epitopes and hybrid loops |
08/18/1998 | US5795911 Using tea catechin |
08/18/1998 | US5795874 Bactericide against gramnegative, grampositive bacteria |
08/18/1998 | US5795865 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof |
08/18/1998 | US5795778 Using enzymatic rna compound |
08/18/1998 | US5795758 DNA encoding histidyl tRNA synthetase variant from Streptococcus pneumoniae |
08/18/1998 | US5795580 Group B streptococcus type V polysaccharide-protein conjugate vaccines |
08/18/1998 | US5795579 Herpes simplex virus VP16 vaccines |
08/18/1998 | US5795572 Monoclonal antibodies and FV specific for CD2 antigen |
08/18/1998 | CA2224123A1 Nucleic acid construct for the cell cycle regulated expression of structural genes |
08/18/1998 | CA2215920A1 Drug binding protein |
08/18/1998 | CA1340005C Pharmaceutical composition for the treatment of psoriasis |
08/13/1998 | WO1998035048A2 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
08/13/1998 | WO1998035039A1 Dendritic cell-derived growth factor |
08/13/1998 | WO1998035024A1 New spumavirus isolated from humans |
08/13/1998 | WO1998035014A2 Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom |
08/13/1998 | WO1998034968A1 Polymers incorporating peptides |
08/13/1998 | WO1998034958A1 O-sulfated bacterial polysaccharides |
08/13/1998 | WO1998034936A1 Carbapenem compounds, use thereof, and intermediate compounds of the same |
08/13/1998 | WO1998034934A1 Amino acid ester containing azole antifungals |
08/13/1998 | WO1998034929A1 Il-8 receptor antagonists |
08/13/1998 | WO1998034918A1 Arylsulfonyl hydroxamic acid derivatives |
08/13/1998 | WO1998034917A2 Synthesis of acyclic nucleoside derivatives |
08/13/1998 | WO1998034642A1 Adoptive immunotherapy utilizing heat shock/stress protein-peptide complexes for prevention/treatment of cancer or infectious diseases |
08/13/1998 | WO1998034640A2 Synthetic hiv gag genes |
08/13/1998 | WO1998034629A1 Process for preparing synthetic soil-extract materials and medicaments based thereon |
08/13/1998 | WO1998034622A1 Methods for the administration of amifostine |
08/13/1998 | WO1998034606A1 Melanins with improved ability to inhibit hiv replication |
08/13/1998 | WO1998030693A3 Tumor necrosis factor receptor 5 |
08/13/1998 | WO1998028299A3 Imidazopyridazines |
08/13/1998 | WO1998018917A3 RIBOFLAVIN MUTANTS AS VACCINES AGAINST $i(ACTINOBACILLUS PLEUROPNEUMONIAE) |
08/13/1998 | WO1998004290A3 Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders |
08/13/1998 | CA2625727A1 Methods for the administration of amifostine |
08/13/1998 | CA2280945A1 Adoptive immunotherapy utilizing heat shock/stress protein-peptide complexes for prevention/treatment of cancer or infectious diseases |
08/13/1998 | CA2280704A1 Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom |
08/13/1998 | CA2280287A1 Dendritic cell-derived growth factor |
08/13/1998 | CA2280275A1 New spumavirus isolated from humans |
08/13/1998 | CA2280273A1 Carbapenem compounds, use thereof, and intermediate compounds of the same |
08/13/1998 | CA2280195A1 Synthetic hiv gag genes |
08/13/1998 | CA2280178A1 Melanins with improved ability to inhibit hiv replication |
08/13/1998 | CA2280048A1 Il-8 receptor antagonists |
08/12/1998 | EP0857787A2 Histidine kinase from Staphylococcus aureaus |
08/12/1998 | EP0857786A1 RNA dependent amidotransferase B from Staphylococcus Aureus |
08/12/1998 | EP0857785A1 RNA dependent amidotransferase C from Staphylococcus Aureus |
08/12/1998 | EP0857781A2 Human endoglingene promoter and use thereof |
08/12/1998 | EP0857428A2 Dietetic soy based products and method for production thereof |
08/12/1998 | EP0857214A1 Novel saliva binding protein |
08/12/1998 | EP0857213A1 Novel adherence factors of non pathogenic microorganisms and applications thereof for screening miroorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors |
08/12/1998 | EP0857175A1 Novel human cysteine protease |
08/12/1998 | EP0857069A1 Methods of preserving microorganisms |
08/12/1998 | EP0857068A1 Immunotherapy of cancer and infectious disease using antigen-presenting cells sensitized with heat shock protein-antigen complexes |
08/12/1998 | EP0857059A1 Novel adjuvant compositions and vaccine formulations comprising same |
08/12/1998 | EP0751947B1 Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity |
08/12/1998 | EP0696275B1 Vitamin d amide derivatives |
08/12/1998 | EP0686143B1 Unsaturate amino compounds for use as anticancer and antiprotozoic agent |
08/12/1998 | EP0650474B1 Novel piperidyl amides, sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis |
08/12/1998 | EP0631472B1 Antiviral condoms |
08/12/1998 | EP0613379B1 Therapeutic compounds |
08/12/1998 | CN1190390A Nitric oxide synthase inhibitors derived from cyclic amidines |
08/12/1998 | CN1190349A Viral agent associated with mystery swine disease |
08/12/1998 | CN1190346A Pharmaceutical composition comprising lactobacillus plantarum and arginine |
08/12/1998 | CN1190097A Propiophenone derivatives and process for preparing the same |
08/11/1998 | US5792842 Ganglioside GM3 derivative having fluorine atom at 9-position of sialic acid and intermediates therefor |
08/11/1998 | US5792790 Method for improving weight gain and feed utilization in livestock |
08/11/1998 | US5792782 Treating cryptococcus neoformans |
08/11/1998 | US5792781 Antifungal agents, processes for the preparation thereof, and intermediates |
08/11/1998 | US5792780 Fungicides |
08/11/1998 | US5792777 Biphenyl quinuclidines |
08/11/1998 | US5792772 Enatiomerically pure hydroxylated xanthine compounds |
08/11/1998 | US5792765 Substituted oxazolidinones |
08/11/1998 | US5792756 Phosphonate nucleotide analog antiviral/antitumor agent for oral drug delivery |
08/11/1998 | US5792746 Administering to the patient to treat pneumocystis pneumonia; antibiotics and fungicides; cyclic hexpeptides |
08/11/1998 | US5792645 Protein-polycation nucleic acid complexes and methods of use |
08/11/1998 | US5792462 Alphavirus RNA replicon systems |
08/11/1998 | US5792444 Labeled chemotactic peptides to image focal sites of infection or inflammation |
08/11/1998 | CA2064160C Use of combinations of gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
08/11/1998 | CA2029599C Medicaments containing as active substance sulphur-containing carboxylic acids and their use in combating retroviruses |
08/11/1998 | CA1339990C Compositions and method for the treatment or prophylaxis of sepsis or septic shock |
08/07/1998 | CA2222987A1 Novel compounds |